Category:Klaus Charisse of Acton MA (US)

Klaus Charisse of Acton MA (US)

Executive Summary

Klaus Charisse of Acton MA (US) is an inventor who has filed 2 patents. Their primary areas of innovation include Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; {Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing (when used in plants (2 patents), MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media (2 patents), MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media (2 patents), and they have worked with companies such as Alnylam Pharmaceuticals, Inc. (2 patents). Their most frequent collaborators include (2 collaborations), (2 collaborations), (2 collaborations).

Patent Filing Activity

File:Klaus Charisse of Acton MA (US) Monthly Patent Applications.png

Technology Areas

File:Klaus Charisse of Acton MA (US) Top Technology Areas.png

List of Technology Areas

• C12N15/113 (Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; {Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing (when used in plants): 2 patents
• C12N2310/14 (MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media): 2 patents
• C12N2310/351 (MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media): 2 patents
• A61K47/549 ({Sugars, nucleosides, nucleotides or nucleic acids}): 1 patents
• A61K45/06 (Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca): 1 patents
• C12N2310/343 (Spatial arrangement of the modifications): 1 patents
• C12N2320/32 (MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media): 1 patents
• C12N2320/51 (MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media): 1 patents
• C12N2310/315 (of the backbone): 1 patents

Companies

File:Klaus Charisse of Acton MA (US) Top Companies.png

List of Companies

• Alnylam Pharmaceuticals, Inc.: 2 patents

Collaborators

• Donald Foster of Attleboro MA (US) (2 collaborations)
• Martin A. Maier of Belmont MA (US) (2 collaborations)
• Stuart Milstein of Arlington MA (US) (2 collaborations)
• Brian Bettencourt of Groton MA (US) (1 collaborations)
• Gregory Hinkle of Plymouth MA (US) (1 collaborations)
• Satyanarayana Kuchimanchi of Acton MA (US) (1 collaborations)
• Mark K. Schlegel of Boston MA (US) (1 collaborations)
• Maja Janas of Cambridge MA (US) (1 collaborations)
• Vasant R. Jadhav of Sharon MA (US) (1 collaborations)
• Muthiah Manoharan of Weston MA (US) (1 collaborations)
• Kallanthottathil G. Rajeev of Wayland MA (US) (1 collaborations)
• Alexander V. Kel'in of Swampscott MA (US) (1 collaborations)
• Jayaprakash K. Nair of Cambridge MA (US) (1 collaborations)
• Shigeo Matsuda of Cambridge MA (US) (1 collaborations)
• Muthusamy Jayaraman of Cambridge MA (US) (1 collaborations)
• Alfica Sehgal of Medford MA (US) (1 collaborations)
• Christopher Brown of Cambridge MA (US) (1 collaborations)
• Kevin Fitzgerald of Brookline MA (US) (1 collaborations)